Wall Street Breakfast

Lilly weight loss drug succeeds in sleep apnea trial

04.17.2024 - By Seeking AlphaPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Zepbound sees positive outcomes in Phase 3 clinical trials for sleep disorder. (0:16) Walmart teams up with Jessica Simpson. (3:25) Cathie Wood's flagship ARRK ETF falls below key technical level. (3:42)Show NotesWedbush says these housing stocks can benefit from rising interest ratesEpisode transcripts seekingalpha.com/wsbSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

More episodes from Wall Street Breakfast